These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30982272)

  • 1. [Epidemiological analysis of viral hepatitis E in China, 2004-2017].
    Sun XJ; Zhang GM; Zheng H; Miao N; Wang HQ; Yin ZD; Wang FZ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Apr; 53(4):382-387. PubMed ID: 30982272
    [No Abstract]   [Full Text] [Related]  

  • 2. [Epidemiological characteristics of hepatitis A and hepatitis E in different periods of vaccination in China, 2004-2015].
    Sun XJ; Wang FZ; Zheng H; Miao N; Wang HQ; Yin ZD; Zhang GM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Oct; 39(10):1351-1355. PubMed ID: 30453436
    [No Abstract]   [Full Text] [Related]  

  • 3. [Epidemiological analysis of viral hepatitis A in China, 2004-2015].
    Sun XJ; Wang FZ; Zheng H; Miao N; Yuan QL; Wang HQ; Yin ZD; Zhang GM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Dec; 51(12):1091-1096. PubMed ID: 29262490
    [No Abstract]   [Full Text] [Related]  

  • 4. Changing Epidemiological Characteristics of Hepatitis A in Zhejiang Province, China: Increased Susceptibility in Adults.
    Wang Z; Chen Y; Xie S; Lv H
    PLoS One; 2016; 11(4):e0153804. PubMed ID: 27093614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute sporadic hepatitis E in the Zhejiang coastal area of China: a 14-year hospital-based surveillance study.
    Tan J; Chen Y; Wang L; Chan TC; Amer S; Xu X; Cai J; Li W; Zheng X; Zhou M; Qin S; Zhao N; Miao Z; Liu S
    Virol J; 2019 Feb; 16(1):16. PubMed ID: 30717759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing incidence of reported viral hepatitis in China from 2004 to 2016: an observational study.
    Zhang M; Wu R; Xu H; Uhanova J; Gish R; Wen X; Jin Q; Gerald MY; Nguyen MH; Gao Y; Niu J
    BMJ Open; 2019 Aug; 9(8):e028248. PubMed ID: 31427323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial.
    Zhu FC; Zhang J; Zhang XF; Zhou C; Wang ZZ; Huang SJ; Wang H; Yang CL; Jiang HM; Cai JP; Wang YJ; Ai X; Hu YM; Tang Q; Yao X; Yan Q; Xian YL; Wu T; Li YM; Miao J; Ng MH; Shih JW; Xia NS
    Lancet; 2010 Sep; 376(9744):895-902. PubMed ID: 20728932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The coverage of hepatitis A vaccine among 2-29 year olds and the reporting incidence of hepatitis A in China, 2014].
    Wang FZ; Zheng H; Liu JH; Sun XJ; Miao N; Shen LP; Zhang GM; Cui FQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Aug; 37(8):1099-104. PubMed ID: 27539340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes of epidemiological characteristics of measles in Beijing before and after supplementary immunization campaigns of measles vaccine in 2010].
    Ma R; Lu L; Zhang Z; Suo L; Li J; Chen M; Yu X
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Dec; 49(12):1036-41. PubMed ID: 26887295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the duplicate notifiable reporting of hepatitis B infection in Zhejiang province, China, 2005-2015.
    He H; Zhou Y; Xie S
    Vaccine; 2017 Aug; 35(36):4702-4706. PubMed ID: 28750855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B in Poland in 2012.
    Stępień M; Piwowarow K
    Przegl Epidemiol; 2014; 68(2):257-63, 363-7. PubMed ID: 25135511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiological study on risk factors of hepatitis E in Yantai, Shandong province].
    Jiang M; Cui WH; Li B; Wang YL; Gong LF; Liu J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1417-20. PubMed ID: 21223678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use the Markov-decision tree model to optimize vaccination strategies of hepatitis E among women aged 15 to 49].
    Chen ZM; Ji SB; Shi XL; Zhao YY; Zhang XF; Jin H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Feb; 38(2):267-271. PubMed ID: 28231679
    [No Abstract]   [Full Text] [Related]  

  • 14. A hepatitis E outbreak by genotype 4 virus in Shandong province, China.
    Zhang L; Yan B; Xu A
    Vaccine; 2016 Jul; 34(33):3715-8. PubMed ID: 27318419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis E vaccine: why wait?
    Lancet; 2010 Sep; 376(9744):845. PubMed ID: 20833284
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis E should be a global public health priority: recommendations for improving surveillance and prevention.
    Kirkwood CD; Dobscha KR; Steele AD
    Expert Rev Vaccines; 2020 Dec; 19(12):1129-1140. PubMed ID: 33441054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the epidemiology of hepatitis A in three socio-economic regions of China, 1990-2017.
    Sun XJ; Zhang GM; Zhou RJ; Zheng H; Miao N; Yin ZD; Wang FZ
    Infect Dis Poverty; 2019 Oct; 8(1):80. PubMed ID: 31578150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity.
    Zhang J; Zhang XF; Zhou C; Wang ZZ; Huang SJ; Yao X; Liang ZL; Wu T; Li JX; Yan Q; Yang CL; Jiang HM; Huang HJ; Xian YL; Shih JW; Ng MH; Li YM; Wang JZ; Zhu FC; Xia NS
    Clin Microbiol Infect; 2014 Jun; 20(6):O397-405. PubMed ID: 24118636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A sero-epidemiological study of hepatitis E among general population in Shandong Province of China in 2014].
    Yan BY; Zhang L; Lyu JJ; Feng Y; Liu JY; Wu WL; Song LZ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jul; 51(7):587-592. PubMed ID: 28693081
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis E vaccine: WHO position paper, May 2015--Recommendations.
    WHO
    Vaccine; 2016 Jan; 34(3):304-5. PubMed ID: 26232546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.